TECHNEGAS KIT
Growthkit for the preparation of technetium tc 99m-labeled carbon inhalation aerosol
NDAINHALATIONAEROSOL
Approved
Sep 2023
Lifecycle
Growth
Competitive Pressure
8/100
Data completeness
2/8 — Basic
Drug data last refreshed 11h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
TECHNEGAS KIT is a preparation kit for creating technetium Tc 99m-labeled carbon inhalation aerosol, used as a diagnostic imaging agent for pulmonary ventilation assessment. The product works through mechanical deposition of inhaled aerosol particles on the epithelium of ventilated bronchioles and alveoli, with distribution determined by lung aerodynamic function rather than receptor-mediated mechanisms. This is a diagnostic radiopharmaceutical indicated for lung ventilation imaging.
Growth4.6 years to LOE
Early-stage product in growth phase post-approval with minimal current linked commercial roles, suggesting opportunity to build market presence and expand team infrastructure.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Why This Matters for Your Career
LOE in ~5 years — strategic planning for patent cliff underway
Worked on TECHNEGAS KIT at Cyclomedica? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.